Phenotypic screening of candidate drugs to treat alzheimers disease
Ended Purchase Order Awarded Last action
- Contract number
- 75N95020P00696
- Awardee
-
QPS Austria GMBH UEI V615KLQ23YA5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $298,624
Award facts
- Opportunity
-
- Phenotypic Screening of Candidate Drugs to Treat Alzheimer’s Disease Solicitation · 75N95020Q00216 · Posted Aug 27, 2020
- Contract value 100% obligated
- $298,624.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Austria
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $298,624 |
About this award
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $298,624 firm fixed-price purchase order to QPS Austria GmbH to provide phenotypic screening services to identify effective treatments for Alzheimer's disease. The requirement, as outlined in the solicitation, is for the contractor to test approximately 20 FDA-approved drugs that have been nominated as potential treatments in order to determine if exposure is associated with lower Alzheimer's risk and amelioration of cellular pathological changes. There is no set-aside designation for this requirement. Performance will take place in Grambach, Austria over a 12-month period to support the National Institute on Aging's efforts to advance Alzheimer's disease research.
Quick answers
Who was awarded contract 75N95020P00696?
75N95020P00696 was awarded to QPS Austria GMBH by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2020.
How much is contract 75N95020P00696 worth?
The government has obligated $298,624 on 75N95020P00696.
Which agency awarded contract 75N95020P00696?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00696, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95020P00696 competed?
The extent of competition for 75N95020P00696 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award